No abstract available
MeSH terms
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Blood Coagulation / drug effects
-
Blood Coagulation / genetics
-
Blood Component Transfusion
-
Child
-
Enoxaparin / therapeutic use
-
Factor V / genetics*
-
Humans
-
Male
-
Mutation*
-
Protein C / therapeutic use*
-
Protein C Deficiency / blood
-
Protein C Deficiency / drug therapy*
-
Protein C Deficiency / genetics
-
Prothrombin / genetics*
-
Purpura Fulminans / drug therapy*
-
Purpura Fulminans / genetics
-
Recombinant Proteins / therapeutic use
-
Treatment Outcome
-
Warfarin / adverse effects
-
Warfarin / therapeutic use*
Substances
-
Anticoagulants
-
Enoxaparin
-
Protein C
-
Recombinant Proteins
-
factor V Leiden
-
Warfarin
-
Factor V
-
Prothrombin
-
drotrecogin alfa activated